Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sherman Matthew L
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   197,506    

Indirect Shares

   8,500      
Direct Value   $15,072,557    

Indirect Value

   $1,519,375      
Total Shares   206,006      
Total Value   $16,591,932      


Acceleron Pharma Inc $12,292,101 Pulmatrix Inc $0 Deciphera Pharmaceuticals, Inc. $2,780,456 Acceleron Pharma Inc $12,292,101 Pulmatrix Inc $0 Deciphera Pharmaceuticals, Inc. $2,780,456
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    13    

     Stock price went up :
    0   
    8    
     Stock price went down :
    0   
    5    
   
     Gain/Loss Ratio :
   0.0   
   1.6   
     Percentage Gain/Loss :
     0.0%
 377.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Acceleron Pharma Inc XLRN EVP & Chief Medical Of... 2018-04-03 68,767 2018-04-03 8,500    Premium*  
            Pulmatrix Inc PULM Director 2018-04-03 20,000 2018-04-03 0    Premium*  
            Deciphera Pharmaceuticals, Inc. DCPH 2024-02-16 108,739 2019-10-15 0    Premium*  
* Premium Members only  

Records found :    122         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-09-03 4 OE $1.80 $7,200 D/D 4,000 31,858 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-09-03 4 AS $25.80 $103,320 D/D (4,000) 27,858 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-09-03 4 AS $25.79 $25,790 I/I (1,000) 27,500 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-09-18 4 AS $25.47 $101,880 D/D (4,000) 23,858 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-09-18 4 AS $25.50 $25,500 I/I (1,000) 26,500 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-10-08 4 OE $1.80 $7,348 D/D 4,082 27,940 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-10-08 4 AS $29.17 $120,396 D/D (4,082) 23,858 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-10-08 4 AS $29.27 $29,498 I/I (1,000) 25,500 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-10-20 4 AS $29.10 $114,014 D/D (3,918) 19,940 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-10-20 4 AS $29.12 $29,120 I/I (1,000) 24,500 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-11-12 4 AS $32.64 $33,064 I/I (1,000) 23,500 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-11-12 4 OE $1.80 $11,986 D/D 3,918 23,858 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-11-12 4 AS $32.43 $129,748 D/D (3,918) 19,940 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-11-18 4 OE $0.48 $1,959 D/D 4,082 24,022 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-11-18 4 AS $33.54 $137,817 D/D (4,082) 19,940 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-11-18 4 AS $33.42 $33,747 I/I (1,000) 22,500 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-12-10 4 OE $5.08 $20,320 D/D 4,000 22,004 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-12-10 4 AS $43.16 $43,445 I/I (1,000) 21,500 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-12-10 4 AS $43.32 $173,876 D/D (4,000) 18,004 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-12-17 4 OE $3.88 $7,760 D/D 2,000 20,004 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-12-18 4 AS $40.19 $40,190 I/I (1,000) 20,500 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-12-18 4 AS $40.13 $160,614 D/D (4,000) 20,004 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2014-12-18 4 OE $0.48 $1,920 D/D 4,000 24,004 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2015-01-20 4 OE $0.48 $10,048 D/D 5,600 24,004 0 -
XLRN Acceleron Pharma Inc SVP & Chief Medical Officer   •       –      –    2015-01-20 4 AS $41.23 $233,210 D/D (5,600) 24,004 0 -
  122  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us